Similarly, CDKN2A DEL increased the risk of distant metastasis in multiple cancers, including HNSC, KIRC, PAAD, skin cutaneous melanoma (SKCM), and stomach adenocarcinoma (STAD) in TCGA cohort [58]. This evidence concerns the gene CDKN2A and pancreatic adenocarcinoma.